Home LiteratureArticle Details
PMID: 12531876 Published · ppublish English Comment Journal Article Research Support, Non-U.S. Gov't

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

The Journal of clinical investigation ·Vol. 111 ·No. 2 ·2003-01-00 ·Pages 209-16

Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ

Abstract

Restrictive cardiomyopathy (RCM) is an uncommon heart muscle disorder characterized by impaired filling of the ventricles with reduced volume in the presence of normal or near normal wall thickness and systolic function. The disease may be associated with systemic disease but is most often idiopathic. We recognized a large family in which individuals were affected by either idiopathic RCM or hypertrophic cardiomyopathy (HCM). Linkage analysis to selected sarcomeric contractile protein genes identified cardiac troponin I (TNNI3) as the likely disease gene. Subsequent mutation analysis revealed a novel missense mutation, which cosegregated with the disease in the family (lod score: 4.8). To determine if idiopathic RCM is part of the clinical expression of TNNI3 mutations, genetic investigations of the gene were performed in an additional nine unrelated RCM patients with restrictive filling patterns, bi-atrial dilatation, normal systolic function, and normal wall thickness. TNNI3 mutations were identified in six of these nine RCM patients. Two of the mutations identified in young individuals were de novo mutations. All mutations appeared in conserved and functionally important domains of the gene. This article was published online in advance of the print edition. The date of publication is available from the JCI website, http://www.jci.org.

MeSH Terms
Adolescent Adult Cardiomyopathy, Hypertrophic/genetics Cardiomyopathy, Restrictive/genetics Child Child, Preschool Female Genetic Linkage Humans Male Middle Aged Mutation Troponin I/genetics
Chemicals
Troponin I
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Mogensen Jens
Department of Cardiological Sciences, St. George's Hospital Medical School, Tooting, London, United Kingdom. jmogense@sghms.ac.uk
Kubo Toru
Duque Mauricio
Uribe William
Shaw Anthony
Murphy Ross
Gimeno Juan R
Elliott Perry
McKenna William J
References (32)
32 references, click to expand
  1. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.
    Heart. 1997 Feb;77(2):130-2 PMID: 9068395
  2. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
    J Biol Chem. 2002 Apr 5;277(14):11670-8 PMID: 11801593
  3. Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy.
    J Mol Cell Cardiol. 2000 Mar;32(3):521-5 PMID: 10731450
  4. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
    J Biol Chem. 2000 Jul 21;275(29):22069-74 PMID: 10806205
  5. Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood.
    Circulation. 1978 Feb;57(2):278-85 PMID: 618615
  6. Ultrastructural features of hypertrophied human ventricular myocardium.
    Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):207-38 PMID: 152939
  7. Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease.
    J Clin Ultrasound. 1979 Dec;7(6):439-47 PMID: 118184
  8. Idiopathic restrictive cardiomyopathy.
    Circulation. 1984 Aug;70(2):165-9 PMID: 6733871
  9. The surgical pathology of hypertrophic cardiomyopathy.
    Arch Pathol Lab Med. 1987 Mar;111(3):257-60 PMID: 3827529
  10. Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy.
    Br Heart J. 1990 Feb;63(2):114-8 PMID: 2317404
  11. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.
    Cell. 1990 Sep 7;62(5):999-1006 PMID: 1975517
  12. Familial cardiomyopathy with variable hypertrophic and restrictive features and common HLA haplotype.
    Isr J Med Sci. 1992 May;28(5):277-80 PMID: 1597356
  13. Assignment of patients into the classification of cardiomyopathies.
    Circulation. 1992 Nov;86(5):1622-33 PMID: 1423973
  14. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
    Circulation. 1996 Mar 1;93(5):841-2 PMID: 8598070
  15. Isolation and characterization of the human cardiac troponin I gene (TNNI3).
    Genomics. 1996 Jul 1;35(1):11-23 PMID: 8661099
  16. Restrictive cardiomyopathy.
    N Engl J Med. 1997 Jan 23;336(4):267-76 PMID: 8995091
  17. The relationship between biological activity and primary structure of troponin I from white skeletal muscle of the rabbit.
    Biochem J. 1976 Feb 1;153(2):375-87 PMID: 179535
  18. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population.
    Circulation. 1997 Jul 1;96(1):214-9 PMID: 9236436
  19. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
    Nat Genet. 1997 Aug;16(4):379-82 PMID: 9241277
  20. Morphologic spectrum of primary restrictive cardiomyopathy.
    Am J Cardiol. 1997 Oct 15;80(8):1046-50 PMID: 9352976
  21. Assignment of the human cardiac troponin I gene (TNNI3) to chromosome 19q13.4 by radiation hybrid mapping.
    Cytogenet Cell Genet. 1997;79(3-4):272-3 PMID: 9605869
  22. Troponin I: inhibitor or facilitator.
    Mol Cell Biochem. 1999 Jan;190(1-2):9-32 PMID: 10098965
  23. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.
    J Clin Invest. 1999 May 15;103(10):R39-43 PMID: 10330430
  24. Complexity in simplicity: monogenic disorders and complex cardiomyopathies.
    J Clin Invest. 1999 Jun;103(11):1483-5 PMID: 10359556
  25. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.
    Circulation. 2000 Aug 8;102(6):663-9 PMID: 10931807
  26. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy.
    Circulation. 2000 Aug 22;102(8):876-82 PMID: 10952956
  27. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy.
    Circ Res. 2000 Oct 27;87(9):805-11 PMID: 11055985
  28. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
    N Engl J Med. 2000 Dec 7;343(23):1688-96 PMID: 11106718
  29. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.
    Cell. 2001 Feb 23;104(4):557-67 PMID: 11239412
  30. Development and application of linkage analysis in genetic diagnosis of familial hypertrophic cardiomyopathy.
    J Med Genet. 2001 Mar;38(3):193-8 PMID: 11303515
  31. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.
    Circulation. 2001 Sep 18;104(12):1380-4 PMID: 11560853
  32. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    J Mol Cell Cardiol. 2001 Dec;33(12):2095-107 PMID: 11735257
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2003-01-00
Pages
209-16
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC151864
Subset
IM
Corrections
ErratumIn
-
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com